Stock Taper
SCREENER COMPARE ANY 2 STOCKS
RDHL
REDHILL BIOPHARMA LTD.
NASDAQ
$0.66
▲ UP 4.92% (0.03)

KEY STATISTICS

Market Cap$2.08 M
52w High$2.79
52w Low$0.57
Dividend Yield—
Frequency—
P/E0.13
Volume41.13K
Shares Out.3.14M

COMPANY

LEADERSHIP

Dror Ben-Asher
CHIEF EXECUTIVE
Dror Ben-Asher

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 7, 2013
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
13

UPCOMING EARNINGS

DateAug 31, 2026
DayMonday
Rev. Est.$22.70M
AUG
31
MON

SPLIT RECORD

DATETYPERATIO
2024-08-20Reverse1:25
2023-03-23Reverse1:40

PRICE

$0.66 ▲ UP 4.92% (+$0.03)
OVERLAYS
$0.63$0.65$0.68$0.709:43 AM10:46 AM11:48 AM12:51 PM1:54 PM2:56 PM3:59 PM0.66

About RedHill Biopharma Ltd.

https://www.redhillbio.com ↗

RedHill Biopharma Ltd. is an Israeli biotech focused on gastrointestinal and infectious diseases, with marketed drugs like Movantik and Talicia, and late-stage pipeline candidates including treatments for COVID-19, Crohn's, and Helicobacter pylori.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT REDHILL BIOPHARMA LTD. IS KNOWN FOR

Talicia® (omeprazole, amoxicillin, and rifabutin)
Talicia® (omeprazole, amoxicillin, and rifabutin)

Talicia® is an FDA-approved oral prescription for H. pylori infection in adults, marketed by RedHill Biopharma in the U.S. and involved in recent co-commercialization partnerships.

COMPETITORS

COMPETITOR
ABBV COMPARE
PHAT COMPARE
TAK COMPARE

Revenue by Products

IconPRODUCTQ2-2020Q2-2021Q2-2022
Movantik$19.95M $19.21M ▼$16.13M ▼

INSTITUTIONAL OWNERSHIP

SHARES OWNED
4.13%
HOLDERS
7
TOP 7 OF 7 · RANKED BY POSITION SIZE
Menta Capital LLC
56.7K sh · $368K
Eaton Vance Management
40.4K sh · $20K
Aperio Group, LLC
18.4K sh · $149K
Cibc Bank Usa
12.0K sh · $73K
Ladenburg Thalmann Financial Services Inc.
2.3K sh · $14K
Magee Thomson Investment Partners LLC
45 sh · $0
Concourse Financial Group Securities, Inc.
0 sh · $0

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF OPERATING OFFICER
Raday Gilead
Sale · 14.1M shares
2026-07-10
★
OFFICER: CHIEF OPERATING OFFICER
Raday Gilead
Purchase · 28.1M shares
2026-07-10
★
OFFICER: CHIEF OPERATING OFFICER
Raday Gilead
Sale · 15.7M shares
2026-04-06
★
OFFICER: CHIEF OPERATING OFFICER
Raday Gilead
Purchase · 30.8M shares
2026-04-06

SECTORS PEERS

PEERPRICE
CNSP$5.52COMPARE
BGMS$0.86COMPARE
GCTK$0.28COMPARE
IMCC$3.41COMPARE
SXTP$1.03COMPARE
AKAN$3.89COMPARE
JAGX$0.81COMPARE
MSPR$0.00COMPARE